Epithalon was originally developed as a synthetic analog of epithalamin, a pineal gland extract. Consequently, a significant body of research has investigated its effects on pineal gland function, particularly melatonin production. Melatonin is a hormone produced by the pineal gland that regulates circadian rhythm (the sleep-wake cycle) and functions as an antioxidant.³

Animal studies have shown that Epithalon administration increased melatonin production in aged rats, potentially restoring age-related declines in melatonin synthesis. This research is relevant because melatonin production decreases significantly with age in both humans and animal models, and reduced melatonin is associated with disrupted sleep patterns, reduced antioxidant capacity, and altered immune function in aging organisms.

Several longitudinal studies in animal models have investigated Epithalon's effects on lifespan and age-related parameters. Research in aging rats and mice showed that Epithalon treatment was associated with improvements in multiple biomarkers of aging, including reduced incidence of spontaneous tumors, improved immune function parameters, and normalized circadian rhythm disruption in aged animals.⁴

A notable series of studies by Anisimov et al. investigated Epithalon in cancer-prone mouse strains and reported that treatment was associated with reduced spontaneous tumor incidence and increased mean lifespan. However, these studies were conducted primarily in a single research program, and the tumor biology of the specific mouse strains used may limit generalizability.⁵

Epithalon has been studied for its effects on the neuroendocrine system — the network of glands and hormones that regulate body function. Research in aged rats demonstrated that Epithalon treatment normalized age-related changes in reproductive hormone levels and adrenal cortex function. These findings are interpreted in the context of Epithalon's effects on the pineal gland, which serves as a master regulator that influences other endocrine systems through melatonin signaling.

The neuroendocrine research suggests that Epithalon's effects may extend beyond direct telomerase activation to include broader hormonal regulation mediated through the pineal-hypothalamic axis.